Quality & complianceOfficial

Quest Diagnostics pays $13m to resolve Medicare and Medicaid kickback allegations over Giants suite tickets

🇺🇸 HHS OIG · Fri 13 Nov 2026

The New Jersey-based laboratory group has paid $13,014,576 plus interest over claims that exclusive entertainment perks were used to induce referrals paid for by federal healthcare programmes.

Quest Diagnostics has paid $13,014,576 plus interest to resolve allegations that it submitted false claims to Medicare and to the New York and New Jersey Medicaid programmes. The settlement was announced by U.S. Attorney Robert Frazer, and the HHS Office of Inspector General listed it on 13 November 2026.

According to the allegations, Quest offered health care providers and executives illegal kickbacks in the form of valuable, exclusive entertainment events. These included free tickets to suite seats at MetLife Stadium for New York Giants home games. The alleged aim was to induce referrals of business that federal healthcare programmes then paid for.

The action was recorded as taking place on 6 November 2026 at the U.S. Attorney's Office for the District of New Jersey, and is categorised as both criminal and civil. The company is based in Secaucus, New Jersey. A Corporate Integrity Agreement with Quest Diagnostics, Incorporated appears among the related items, but the source gives no detail on its terms.

The source describes the matter as allegations that have been resolved. It does not set out any admission of liability or further conditions of the settlement.

What it means for your team

  • Hospitality and entertainment offered to referral sources, including event tickets, can be treated as remuneration in kickback allegations where federal programme claims are involved.
  • Laboratory and life-science compliance teams may wish to check that gifts, hospitality and events involving clinicians and executives are covered by policy, approval and recording controls.
  • Claims for Medicare and state Medicaid reimbursement tied to improperly induced referrals can bring false claims exposure, as this settlement illustrates.
  • The listing of a Corporate Integrity Agreement alongside the settlement suggests compliance oversight is part of the wider resolution, though the source does not give its terms.

Official source: HHS OIG ↗

Article written by VigiEye from the official source (HHS OIG). AI-assisted; check the source before acting.

More Quality & compliance All →